Dark Pharma · DP-023
SHE PAID THEM TWELVE DOLLARS. THEY CAME BACK TWICE A WEEK. THE MEDICINE SOLD FOR NINETEEN THOUSAND.
Severe health risks plagued donors at Veridian BioSource’s plasma centers, where compensation was merely twelve dollars per donation. Despite the grim conditions, many returned bi-weekly to meet financial needs, with the company profiting significantly from their plasma sales.
Case Assets
The Case Debrief is free to view. Full Case Study, Teaching Notes, Slide Deck, Discussion Guide, and Assessment are available with a Premium subscription.
Brief the Board
PREMIUM
🔒 Unlock
Learn the Case
FREE — included
Study the Case
PREMIUM
🔒 Unlock
Teach the Case
PREMIUM
🔒 Unlock
Present the Case
PREMIUM
🔒 Unlock
Run a Team Discussion
PREMIUM
🔒 Unlock
Test Your Judgement
PREMIUM
🔒 Unlock
Watch the Full Episode
The complete cinematic audio documentary — Dark Pharma
Unlock the Full Case Library
Get every Case Study, Slide Deck, Teaching Notes, Discussion Guide, and Assessment — across a growing library of business cases.
View Pricing →Related Cases
Cases that share a governance or behavioural model with this one.
Dark Pharma
DP-021
SHE CHANGED THE PRICE IN THE SYSTEM. THE PATIENTS COULDN'T AFFORD IT. ...
Shared: Stakeholder Theory, Ethical Decision-Making Model, Risk Management Framework
The Raid
HJ-041
He Fired His Own Father The Week The Buyout Closed.
Shared: Risk Management Framework, Stakeholder Theory
Dark Pharma
DP-040
SHE RAN THE META-ANALYSIS IN 2006. THE REVIEW HAPPENED AT SENIOR LEVEL...
Shared: Risk Management Framework, Ethical Decision-Making Model
Dark Capital
DC-056
THEY SOLD STORE FOURTEEN ON A WEDNESDAY. CORPORATE CALLED IT PORTFOLIO...
Shared: Stakeholder Theory, Risk Management Framework